| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |